Nantahala Capital Management »

Cytokinetics shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.2M 110k 83.49
2023-09-30 $5.3M 179k 29.46
2023-06-30 $5.8M 179k 32.62
2023-03-31 $1.1M 30k 35.19
2022-12-31 $220k 4.8k 45.82

More positions owned by Nantahala Capital Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Russell 2000 Etf (IWM)
Soleno Therapeutics (SLNO)
Soleno Therapeutics (SLNO)
Establishment Labs Holdings Ord (ESTA)
Establishment Labs Holdings Ord (ESTA)
Meta Financial (CASH)
Meta Financial (CASH)
Costco Wholesale Corporation Put Option (COST)
Costco Wholesale Corporation Put Option (COST)
Imax Corp Cad (IMAX)
Imax Corp Cad (IMAX)
Hilton Grand Vacations (HGV)

View all positions for Nantahala Capital Management

Top funds holding Cytokinetics

Vanguard Group
Wellington Management Company
Caption Management
T. Rowe Price Associates
Henderson Group
Boxer Capital
Citadel Advisors
Partner Fund Management
Logos Global Management
Lord, Abbett & Co
Millennium Management
Artal Group
Bank of New York Mellon
Barclays
Gts Securities

View all funds holding Cytokinetics